Gregor Duwe

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Machine Learning

Radical Prostatectomy

Artificial Intelligence

Renal Cell Carcinoma

Top Venues

World journal of urology

Annals of surgical oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Gregor Duwe, Katharina Boehm, Gerrit Becker, Christian Ruckes, Peter Sparwasser, Maximilian Haack, Robert Dotzauer, Anita Thomas, Rene Mager, Igor Tsaur, Christopher C M Neumann, Günther Feick, Günter Carl, Maximilian Peter Brandt, Axel Haferkamp, Thomas Höfner
Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvement. World journal of urology 42 (1) (2024)
Gregor Duwe, Dominique Mercier, Crispin Wiesmann, Verena Kauth, Kerstin Moench, Markus Junker, Christopher C M Neumann, Axel Haferkamp, Andreas Dengel, Thomas Höfner
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology. Cancer medicine 13 (12) (2024)
Gregor Duwe, Axel Haferkamp, Thomas Höfner
Author reply on the Letter to the Editor on "Standardized reports of focal-HIFU results is paramount: a closer look at the Duwe et al.'s cohort on focal HIFU for localized prostate cancer". World journal of urology 42 (1) (2024)
Gregor Duwe, Dominique Mercier, Crispin Wiesmann, Verena Kauth, Kerstin Moench, Markus Junker, Christopher C M Neumann, Axel Haferkamp, Andreas Dengel, Thomas Höfner
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology. Cancer medicine 13 (12) (2024)
Gregor Duwe, Melanie Schmitteckert, Maximilian Haack, Peter Sparwasser, Robert Dotzauer, Anita Thomas, Igor Tsaur, Maximilian Peter Brandt, Martin Kurosch, Rene Mager, Axel Haferkamp, Katharina Boehm, Thomas Höfner
Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. World journal of urology 42 (1) (2024)
Gregor Duwe, Axel Haferkamp, Thomas Höfner
Author reply on the Letter to the Editor on "Standardized reports of focal-HIFU results is paramount: a closer look at the Duwe et al.'s cohort on focal HIFU for localized prostate cancer". World journal of urology 42 (1) (2024)
Gregor Duwe, Mohamed M Kamal, Crispin Wiesmann, Katarzyna E Banasiewicz, Isabel Wagner, Nikita Dhruva Fischer, Maximilian Haack, Lisa Johanna Frey, Rene Mager, Thomas Höfner, Peter Sparwasser, Igor Tsaur, Christoph Wiesner, Christian Thomas, Joachim Wolfgang Thüroff, Rudolf Hohenfellner, Maximilian Peter Brandt, Axel Haferkamp
Temporal Trends in Urinary Diversion among Patients Undergoing Radical Cystectomy Between 1986 and 2022: Experience at the University Medical Center Mainz with 2224 Cases. Annals of surgical oncology (2024)
Gregor Duwe, Melanie Schmitteckert, Maximilian Haack, Peter Sparwasser, Robert Dotzauer, Anita Thomas, Igor Tsaur, Maximilian Peter Brandt, Martin Kurosch, Rene Mager, Axel Haferkamp, Katharina Boehm, Thomas Höfner
Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. World journal of urology 42 (1) (2024)
Gregor Duwe, Melanie Schmitteckert, Maximilian Haack, Peter Sparwasser, Robert Dotzauer, Anita Thomas, Igor Tsaur, Maximilian Peter Brandt, Martin Kurosch, Rene Mager, Axel Haferkamp, Katharina Boehm, Thomas Höfner
Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. World journal of urology 42 (1) (2024)
Gregor Duwe, Maximilian Peter Brandt, Axel Haferkamp
ASO Author Reflections: Temporal Trends in Urinary Diversion in Radical Cystectomies from Europe's Largest Monocentric Cohort with 2224 Cases Over 36 Years. Annals of surgical oncology (2024)
Gregor Duwe, Katharina Boehm, Gerrit Becker, Christian Ruckes, Peter Sparwasser, Maximilian Haack, Robert Dotzauer, Anita Thomas, Rene Mager, Igor Tsaur, Christopher C M Neumann, Günther Feick, Günter Carl, Maximilian Peter Brandt, Axel Haferkamp, Thomas Höfner
Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvement. World journal of urology 42 (1) (2024)
Gregor Duwe, Mohamed M Kamal, Crispin Wiesmann, Katarzyna E Banasiewicz, Isabel Wagner, Nikita Dhruva Fischer, Maximilian Haack, Lisa Johanna Frey, Rene Mager, Thomas Höfner, Peter Sparwasser, Igor Tsaur, Christoph Wiesner, Christian Thomas, Joachim Wolfgang Thüroff, Rudolf Hohenfellner, Maximilian Peter Brandt, Axel Haferkamp
ASO Visual Abstract: Temporal Trends in Urinary Diversion Among Patients Undergoing Radical Cystectomy Between 1986 and 2022: Experience at the University Medical Center Mainz with 2224 Cases. Annals of surgical oncology (2024)
Gregor Duwe, Katharina Boehm, Maximilian Haack, Peter Sparwasser, Maximilian Peter Brandt, Rene Mager, Igor Tsaur, Axel Haferkamp, Thomas Höfner
Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected. World journal of urology (2023)
Gregor Duwe, Lukas Müller, Christian Ruckes, Nikita Dhruva Fischer, Lisa Johanna Frey, Jan Hendrik Börner, Niklas Rölz, Maximilian Haack, Peter Sparwasser, Tobias Jorg, Christopher C M Neumann, Igor Tsaur, Thomas Höfner, Axel Haferkamp, Felix Hahn, Rene Mager, Maximilian Peter Brandt
Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation. Biomedicines 11 (9) (2023)